for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS Health Corp

CVS.N

Latest Trade

74.01USD

Change

-0.58(-0.78%)

Volume

1,218,397

Today's Range

73.92

 - 

74.62

52 Week Range

51.72

 - 

77.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
74.59
Open
74.16
Volume
1,218,397
3M AVG Volume
134.84
Today's High
74.62
Today's Low
73.92
52 Week High
77.00
52 Week Low
51.72
Shares Out (MIL)
1,300.96
Market Cap (MIL)
97,038.91
Forward P/E
--
Dividend (Yield %)
2.68

Next Event

Q4 2019 CVS Health Corp Earnings Call

Latest Developments

More

Sysco Announces Senior Leadership Changes To Accelerate Next Phase Of Development

CVS Health Sets Quarterly Dividend Of $0.50 Per Share

Centene And CVS Health Announce Agreement For CVS Health To Acquire Illinicare Health

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About CVS Health Corp

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Contact Info

1 Cvs Dr

+1.401.7651500

https://www.cvshealth.com/

Executive Leadership

David W. Dorman

Independent Chairman of the Board

Larry J. Merlo

President, Chief Executive Officer, Director

Eva C. Boratto

Chief Financial Officer, Executive Vice President

Jonathan C. Roberts

Chief Operating Officer, Executive Vice President

Lisa G. Bisaccia

Chief Human Resource Officer, Executive Vice President

Key Stats

2.11 mean rating - 27 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

177.5K

2017

184.8K

2018

194.6K

2019(E)

253.9K
EPS (USD)

2016

5.840

2017

5.900

2018

7.080

2019(E)

7.034
Price To Earnings (TTM)
22.71
Price To Sales (TTM)
0.40
Price To Book (MRQ)
1.55
Price To Cash Flow (TTM)
11.49
Total Debt To Equity (MRQ)
110.29
LT Debt To Equity (MRQ)
102.54
Return on Investment (TTM)
3.24
Return on Equity (TTM)
2.48

Latest News

Latest News

U.S. sues CVS for fraudulently billing Medicare, Medicaid for invalid prescriptions

CVS Health Corp <CVS.N> and its Omnicare unit were sued on Tuesday by the U.S. government, which accused them of fraudulently billing Medicare and other programs for drugs for older and disabled people without valid prescriptions.

U.S. files civil healthcare fraud lawsuit against CVS and its Omnicare unit

The United States said on Tuesday it filed a civil lawsuit accusing CVS Health Corp and its Omnicare unit of fraudulently billing Medicare for drugs dispensed to elderly and disabled people without valid prescriptions.

CVS to increase genetic testing for some cancer patients

(This December 12 story corrects to Missouri from Montana in last paragraph)

CVS to increase genetic testing for some Aetna cancer patients

CVS Health Corp said on Thursday it will make it easier for patients with advanced cancer enrolled in some Aetna insurance plans to receive broad genetic gene sequencing tests that can help identify the best drug or treatment for them.

Centene to sell Illinois health plan unit to CVS to aid merger with WellCare

Health insurer Centene Corp <CNC.N> said on Monday it had entered an agreement to sell its Illinois unit to CVS Health Corp <CVS.N>, moving a step closer to closing its $15.27 billion deal to buy smaller rival WellCare Health Plans Inc <WCG.N>.

Centene to sell Illinois health plan unit to CVS to aid WellCare deal close

Health insurer Centene Corp said on Monday it would divest its Illinois unit, IlliniCare Health Plan Inc, to CVS Health Corp, as it looks to close its $15.27 billion deal to buy smaller rival WellCare Health Plans Inc.

Activist investor Starboard takes stake in CVS: WSJ

Activist investor Starboard Value LP has taken a stake in CVS Health Corp <CVS.N> and held talks with the drugstore chain's management, the Wall Street Journal reported on Monday, citing people familiar with the matter.

Activist investor Starboard takes stake in CVS- WSJ

Activist investor Starboard Value LP has taken a stake in CVS Health Corp and held talks with the drugstore chain's management, the Wall Street Journal reported on Monday, citing people familiar with the matter.

CVS quarterly profit beats expectations; shares rise as it eyes growth

CVS Health Corp <CVS.N> reported higher-than-expected third-quarter profit on Wednesday as medical costs in its Aetna health insurance business came in below forecasts, and the company said its new strategy of using in-pharmacy clinics would contain healthcare spending going...

UPS drone makes first home prescription deliveries for CVS

United Parcel Service Inc <UPS.N> Flight Forward drones have flown prescription medications to the front lawn of a private home and to a retirement center, the UPS unit's first revenue-generating deliveries for drugstore chain CVS Health Corp <CVS.N>.

CVS Health third-quarter profit rises 10% on Aetna sales

Pharmacy chain CVS Health Corp on Wednesday reported a 10.1% rise in profit for the third quarter, helped by its Aetna health insurance business that it acquired last year.

CVS pulls out 22 ounce J&J baby powder from stores

Pharmacy retailer CVS Health Corp said on Thursday it is pulling out 22 ounce bottles of Johnson & Johnson's baby powder from its stores as a precautionary measure.

RPT-FOCUS-CVS drug coverage plan based on outside pricing review is off to a slow start

A CVS Health Corp health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained little traction with customers, according to its top medical executive, and has drawn fierce criticism from patient advocacy groups.

CVS drug coverage plan based on outside pricing review is off to a slow start

A CVS Health Corp <CVS.N> health plan that uses an outside drug pricing group to help it decide whether to cover certain new medicines has gained little traction with customers, according to its top medical executive, and has drawn fierce criticism from patient advocacy...

CVS suspends sales of Zantac brand and generic heartburn drug during safety review

CVS Health Corp said on Saturday it will discontinue sales the popular Zantac heartburn treatment and its own generic ranitidine products from its pharmacies after traces of a known carcinogen were found in some of the products by the U.S. Food and Drug Administration.

BRIEF-CVS Pharmacy Says Co Has Suspended The Sale Of All Zantac Brand Products Until Further Notice

* CVS PHARMACY SAYS CO HAS SUSPENDED THE SALE OF ALL ZANTAC BRAND AND CVS HEALTH BRAND RANITIDINE PRODUCTS UNTIL FURTHER NOTICE

U.S. judge approves CVS purchase of insurer Aetna

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp <CVS.N> to merge with health insurer Aetna said on Wednesday that the agreement was in fact legal under antitrust law.

U.S. judge approves CVS purchase of insurer Aetna

A federal judge reviewing a Justice Department decision to allow U.S. pharmacy chain and benefits manager CVS Health Corp to merge with insurer Aetna said on Wednesday that the agreement was legal under antitrust law.

CVS Health raises 2019 profit forecast after beating profit estimates

CVS Health Corp <CVS.N> raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

CVS Health posts second-quarter profit on Aetna strength

CVS Health Corp on Wednesday reported a profit for the second quarter compared with a year-ago loss, benefiting from its Aetna health insurance acquisition and higher sales of prescription drugs.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up